Engineering antigen as photosensitiser nanocarrier to facilitate ROS triggered immune cascade for photodynamic immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering antigen as photosensitiser nanocarrier to facilitate ROS triggered immune cascade for photodynamic immunotherapy

Published:2020-06 Issue: Volume:244 Page:119964
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Wang Huaiji,Wang Kun,He Lianghua,Liu Ying,Dong Haiqing,Li Yongyong

Funder

National Natural Science Foundation of China

Shanghai Natural Science Foundation

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference48 articles.

1. Nanoparticles in photodynamic therapy;Lucky;Chem. Rev.,2015

2. Overcoming the Achilles’ heel of photodynamic therapy;Fan;Chem. Soc. Rev.,2016

3. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges;Master;J. Contr. Release,2013

4. Multitriggered tumor-responsive drug delivery vehicles based on protein and polypeptide coassembly for enhanced photodynamic tumor ablation;Zhang;Small,2016

5. Photodynamic therapy of cancer. Basic principles and applications;Juarranz;Clin. Transl. Oncol.,2008

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phototherapeutic nanoagents for cancer immunotherapy;Progress in Materials Science;2025-01

2. Colorectal cancer treatment strategy: Targeting O-GlcNAcylation of Yes-associated protein utilizing diselenide-bridged nanovesicles;Chemical Engineering Journal;2024-10

3. Rational design of ROS generation nanosystems to regulate innate immunity of macrophages, dendrtical and natural killing cells for immunotherapy;International Immunopharmacology;2024-09

4. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

5. Nanomaterials: leading immunogenic cell death-based cancer therapies;Frontiers in Immunology;2024-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3